Skip to content
Medical Health Aged Care

She Reached Everest before Taking on Breast Cancer — Now Port Macquarie local tackling Kilimanjaro for First Nations Communities

Breast Cancer Network Australia 2 mins read

Proud Jawoyn and Wiradjuri woman and Port Macquarie local, Kristal Kinsela, is preparing to climb Mount Kilimanjaro to raise critical support for First Nations people affected by breast cancer — less than two years after facing the disease herself.

In 2024, just months after trekking to Everest Base Camp, the business leader and author, and First Nations woman, received a life‑changing breast cancer diagnosis.

Treatment for the mum-of-three involved chemotherapy, a mastectomy, reconstructive surgery and radiation - leaving long-term impacts including medically induced menopause, chronic pain, neuropathy and fatigue.

Now, as she prepares for Kilimanjaro, Kristal says the climb represents far more than a physical challenge.

“People think it’ll be easy — just another mountain — but this mountain is different,” she said. “Breast cancer has changed my body. This climb is about showing the reality of survivorship and advocating for my mob, who deserve culturally safe support when they face breast cancer.”

Kristal is dedicating her climb to raising funds for Breast Cancer Network Australia (BCNA) to ensure First Nations families have access to clear information, culturally aware services and a supportive community throughout their breast cancer journey.

“BCNA walked with me during the hardest time of my life,” she said. “Now I’m climbing for the next sister, aunt, mother or grandmother who needs that same support. No First Nations person should walk this path alone.”

For interviews and further information, contact Steve Milton at Breast Cancer Network Australia at 0423584423 or [email protected]

Donations in support of Kristal’s Kilimanjaro climb can be made online https://bcna.grassrootz.com/bcna-kilimanjaro-2026/kristal-s-team


About us:

Breast Cancer Network Australia (BCNA) is Australia’s leading breast cancer consumer organisation. BCNA provides information and support to those diagnosed and their supporters, opportunities to connect with others going through a similar situation and work to influence a stronger healthcare system to ensure all Australians affected by breast cancer receive the very best care, treatment and support. 


Contact details:

Steve Milton
PR Communications Manager

Breast Cancer Network Australia
0423584423 [email protected]

Media

More from this category

  • Food Beverages, Medical Health Aged Care
  • 11/02/2026
  • 05:30
VicHealth, Australian Medical Association, The George Institute for Global Health

Health leaders push for mandatory Health Star Ratings to protect Australians’ health

Leading health organisations have written to Australia’s food ministers, urging them to make Health Star Ratings mandatory on all packaged foods. They say the…

  • Contains:
  • Medical Health Aged Care
  • 10/02/2026
  • 23:41
Helus Pharma

Helus Pharma Appoints Michael Cola as Chief Executive Officer to Lead Next Phase of Scale and Execution

Former President of Shire PLC’s (“Shire”) Specialty Pharmaceutical business, with more than 30 years of experience across neuroscience, rare disease, and specialty pharmaceuticals, including senior leadership roles at Astra-Merck and AstraZeneca PLCProven leader in late-stage clinical development, global commercialization, and capital formation across central nervous system (“CNS”) programsAppointed as Helus Pharma advances its pipeline toward key clinical milestones, including expected Phase 2 data for HLP004 this quarter and Phase 3 topline data for HLP003 later this yearThis news release constitutes a “designated news release” for the purpose of the Company’s prospectus supplement dated December 30, 2025, to it short form…

  • Medical Health Aged Care
  • 10/02/2026
  • 19:26
Takeda Pharmaceutical Company Limited

U.S. Food and Drug Administration Accepts New Drug Application and Grants Priority Review for Takeda’s Oveporexton (TAK-861) as a Potential First-in-Class Therapy for Narcolepsy Type 1

This FDA Acceptance is a Milestone for People Living with Narcolepsy Type 1 Who Need New and Different Treatment Options Oveporexton is an Orexin…

  • Contains:

Media Outreach made fast, easy, simple.

Feature your press release on Medianet's News Hub every time you distribute with Medianet. Pay per release or save with a subscription.